Are you new to asx Biomeds? They're frequently cashed up beyond...

First 124 Last

Share
Profile

Follow
FameLuck

1,827 Posts.

448

16/05/24

13:19

Post #: 73857142
Share

Originally posted by Roch2077: ↑

your comparing a chart from 2 years ago on what fundamentals?

- Market cap is 10 million and they have a 10 million dollar funding program.

- Directors and CEO will be investing Thursday at 7.5 cents

- CEO coming in with more shares 1 month before GLP results already tells you the success and it’s already de risked from Feb announcement

- phase 1 starts in next 3-4 months and this is the exact same time as the Walter Reed results which have been derisked significantly from 2010 pre clinical studies which gives us another a big cash injection from the US department of defence which is non dilutive to advance phase 2.

- peers on pre clinical work have all traded at 70-100 million market caps and we are now in the same position

Fundamentals and for a drug with 10 million market cap and 10 million in funding with a huge amount of news flow over next 1-3 months and into later this year is just plain stupid. Will rerate very quickly and your Downramping a company that has 10 million in funding when it should be more like its peers at a 70-100 million market cap your funny

Expand

Are you new to asx Biomeds? They're frequently cashed up beyond MC - i feel your whole idea of this being undervalued is based on cash in hand.

I need to go through your history to see what stocks i should blacklist. Between this and IVZ, your grasp on reality is deeply in question.

NYR Price at posting: 6.7¢ Sentiment: None Disclosure: Not Held
3 Upvote

0 Great analysis

Reply